• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性非 BRCA1/BRCA2 乳腺癌肿瘤的转录特征。

Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.

机构信息

Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Center (CNIO) and CIBERER, Madrid, Spain.

出版信息

Int J Cancer. 2011 Jun 1;128(11):2635-44. doi: 10.1002/ijc.25603. Epub 2010 Oct 8.

DOI:10.1002/ijc.25603
PMID:20715112
Abstract

To better understand the alterations present in the group of the so-called BRCAX tumors, we have used a cDNA microarray containing genes related to tumorigenesis and analyzed a series of 49 tumors consisting of 13 BRCA1, 14 BRCAX and 22 sporadic. We have confirmed that the BRCAX tumors are heterogeneous and can be divided in at least two main subgroups, so-called A and B, transcriptionally distinguishable and with different altered pathways within each of the groups. We have found that BRCAX-A and B subgroups, can be classified as Luminal A and Luminal B, respectively, taking into account the intrinsic phenotypes defined for the sporadic breast tumors. We have found that, at the somatic level, the BRCAX-B tumors are identical to their sporadic Luminal B counterparts, whereas BRCAX-A, despite having a Luminal A phenotype, shows additional genomic alterations. We have found 21 deregulated genes in the BRCAX-A group that we have called "the BRCAX susceptibility pathway" and suggested it as a candidate to search for new genes involved in the inherited susceptibility underlying the disease in this group.

摘要

为了更好地理解所谓的 BRCAX 肿瘤中存在的改变,我们使用了包含与肿瘤发生相关基因的 cDNA 微阵列,分析了由 13 个 BRCA1、14 个 BRCAX 和 22 个散发性肿瘤组成的一系列 49 个肿瘤。我们已经证实,BRCAX 肿瘤是异质性的,可以至少分为两个主要亚组,称为 A 和 B,在每个亚组中转录上可区分,并具有不同的改变途径。我们发现,BRCAX-A 和 B 亚组可以分别归类为 Luminal A 和 Luminal B,考虑到为散发性乳腺癌肿瘤定义的内在表型。我们发现,在体细胞水平上,BRCAX-B 肿瘤与其散发性 Luminal B 对应物相同,而 BRCAX-A 尽管具有 Luminal A 表型,但显示出额外的基因组改变。我们在 BRCAX-A 组中发现了 21 个失调基因,我们称之为“BRCAX 易感性途径”,并将其作为候选基因,以寻找该组中与疾病遗传易感性相关的新基因。

相似文献

1
Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.家族性非 BRCA1/BRCA2 乳腺癌肿瘤的转录特征。
Int J Cancer. 2011 Jun 1;128(11):2635-44. doi: 10.1002/ijc.25603. Epub 2010 Oct 8.
2
Molecular classification of familial non-BRCA1/BRCA2 breast cancer.家族性非BRCA1/BRCA2乳腺癌的分子分类
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2532-7. doi: 10.1073/pnas.0533805100. Epub 2003 Feb 27.
3
Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.家族性乳腺癌的表型分析:BRCAx肿瘤与BRCA1、BRCA2携带者及非家族性乳腺癌的比较
Eur J Surg Oncol. 2015 May;41(5):641-6. doi: 10.1016/j.ejso.2015.01.021. Epub 2015 Feb 17.
4
Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.使用 DNA 损伤剂和 RNA 池化技术评估家族性乳腺癌患者中与 BRCA1 和 BRCA2 突变状态相关的表达谱。
PLoS Genet. 2010 Feb 19;6(2):e1000850. doi: 10.1371/journal.pgen.1000850.
5
A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.一种基于BRCA1/BRCA2乳腺癌肿瘤体细胞基因组变化的预测指标可识别出具有BRCA1启动子高甲基化的非BRCA1/BRCA2肿瘤。
Clin Cancer Res. 2005 Feb 1;11(3):1146-53.
6
Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases.家族性乳腺癌中细胞周期蛋白D1表达分析可能有助于区分BRCAX相关病例与BRCA2相关病例。
Mod Pathol. 2008 Oct;21(10):1262-70. doi: 10.1038/modpathol.2008.43. Epub 2008 Mar 7.
7
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.通过杂合性缺失和免疫表型分析对家族性非BRCA1/2乳腺癌进行特征描述。
Clin Cancer Res. 2006 Mar 15;12(6):1693-700. doi: 10.1158/1078-0432.CCR-05-2230.
8
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.通过对遗传相关患者的 aCGH 分析定义非 BRCA1/2 遗传性乳腺癌亚组。
Breast Cancer Res Treat. 2011 Nov;130(2):425-36. doi: 10.1007/s10549-011-1357-x. Epub 2011 Feb 1.
9
miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.巴西 BRCA1 和 BRCA2 种系突变携带者遗传性乳腺癌肿瘤的 miRNA 表达谱分析。
BMC Cancer. 2020 Feb 22;20(1):143. doi: 10.1186/s12885-020-6640-y.
10
Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.在非BRCA1/BRCA2家族性乳腺肿瘤中GATA3频繁发生体细胞突变,但在BRCA1、BRCA2或散发性乳腺肿瘤中并非如此。
Breast Cancer Res Treat. 2010 Jan;119(2):491-6. doi: 10.1007/s10549-008-0269-x. Epub 2009 Feb 3.

引用本文的文献

1
Genome-Wide Gene Expression Analyses of - and -Associated Breast and Ovarian Tumours.与 BRCA1 和 BRCA2 相关的乳腺和卵巢肿瘤的全基因组基因表达分析。
Cancers (Basel). 2020 Oct 16;12(10):3015. doi: 10.3390/cancers12103015.
2
Transcriptional signature of lymphoblastoid cell lines of , and non- high risk breast cancer families.、和非高危乳腺癌家族的淋巴母细胞系的转录特征。
Oncotarget. 2017 Aug 12;8(45):78691-78712. doi: 10.18632/oncotarget.20219. eCollection 2017 Oct 3.
3
Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.
单碱基杂合性缺失可作为特定标记,将BRCAx家族性乳腺癌分类为更具同质性的亚型。
Breast J. 2017 Jul;23(4):479-481. doi: 10.1111/tbj.12777. Epub 2017 Jan 24.
4
Hereditary breast cancer: clinical, pathological and molecular characteristics.遗传性乳腺癌:临床、病理及分子特征
Breast Cancer (Auckl). 2014 Oct 15;8:145-55. doi: 10.4137/BCBCR.S18715. eCollection 2014.
5
MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years.微小RNA可区分35岁及以下患者发生的家族性与散发性非BRCA1/2乳腺癌。
PLoS One. 2014 Jul 9;9(7):e101656. doi: 10.1371/journal.pone.0101656. eCollection 2014.
6
RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.RNA 谱分析揭示非 BRCA1/2 乳腺癌家族中分子亚型的家族聚集性。
BMC Med Genomics. 2014 Jan 31;7:9. doi: 10.1186/1755-8794-7-9.
7
MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.基于 microRNA 的非 BRCA1/2 遗传性乳腺癌肿瘤的分子分类。
Br J Cancer. 2013 Nov 12;109(10):2724-34. doi: 10.1038/bjc.2013.612. Epub 2013 Oct 8.
8
The complex genetic landscape of familial breast cancer.家族性乳腺癌的复杂遗传景观。
Hum Genet. 2013 Aug;132(8):845-63. doi: 10.1007/s00439-013-1299-y. Epub 2013 Apr 5.
9
VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.VEGF、HIF-1α 表达和 MVD 作为家族性乳腺癌中的血管生成网络。
PLoS One. 2013;8(1):e53070. doi: 10.1371/journal.pone.0053070. Epub 2013 Jan 11.